Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.42%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
5.77 Down 0.09(1.54%) May 26, 4:00PM EDT
Prev Close:5.86
Open:5.89
Bid:5.00 x 700
Ask:5.99 x 200
1y Target Est:22.67
Beta:1.61756
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:5.76 - 5.91
52wk Range:4.96 - 14.44
Volume:391,543
Avg Vol (3m):718,773
Market Cap:304.55M
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.54
Quarterly EPS Est (Jun-16) :-0.38
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback